Area of research
Molecular Biology · Oncology
Research interest
Research focused on RANKL and Osteoclast, with related work in Bone marrow, Mesenchymal stem cell, Anabolism. Notable publications include 'Plasmolysis-Inspired Nanoengineering of Functional Yolk–Shell Microspheres with Magnetic Core and Mesoporous Silica Shell', 'Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss', and 'RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation'.
The X-Age Project to construct a Chinese aging clock
Biomimetic Extracellular Vesicles Containing Biominerals for Targeted Osteoporosis Therapy
Standardization and consensus in the development and application of bone organoids
Expert consensus on the bone repair strategy for osteoporotic fractures in China
Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss
RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss
Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion
A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss
RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
Plasmolysis-Inspired Nanoengineering of Functional Yolk–Shell Microspheres with Magnetic Core and Mesoporous Silica Shell
ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins